Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof

Details for Australian Patent Application No. 2003247568 (hide)

Owner Novalar Pharmaceuticals, Inc

Inventors Knowles, Julius; Weber, Eckard; Chen, Andrew, X.

Agent Houlihan2

Pub. Number AU-B-2003247568

PCT Number PCT/US03/19440

PCT Pub. Number WO2004/000219

Priority 60/386,203 20.06.02 US; 60/421,152 24.10.02 US; 60/411,049 17.09.02 US; 60/473,920 29.05.03 US

Filing date 20 June 2003

Wipo publication date 6 January 2004

Acceptance publication date 6 March 2008

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/417 (2006.01)

A61K 31/505 (2006.01) - Pyrimidines

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/04 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/16 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing nitrogen

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

2 October 2003 Complete Application Filed

  Priority application(s): 60/386,203 20.06.02 US; 60/421,152 24.10.02 US; 60/411,049 17.09.02 US; 60/473,920 29.05.03 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003247568

6 March 2008 Application Accepted

  Published as AU-B-2003247568

3 July 2008 Standard Patent Sealed

16 June 2011 Assignment Registered

  Novalar Pharmaceuticals, Inc. The patent has been assigned to Septodont Holding SAS

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003247569-Composition and method for reduction of persistent, bio-accumulative and toxic pollutants in carbochlorination processes

2003247567-A SYSTEM AND METHOD FOR WIRELESSLY TRANSMITTING AND RECEIVING DIGITAL TOKENS USING ACOUSTIC TONES